US 11781156
Plakophillin-2 gene therapy methods and compositions
granted A61KA61K48/005A61K48/0058
Quick answer
US patent 11781156 (Plakophillin-2 gene therapy methods and compositions) held by Tenaya Therapeutics, Inc. expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Tenaya Therapeutics, Inc.
- Grant date
- Tue Oct 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K48/005, A61K48/0058, A61K48/0075, A61P